1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

André Faldt (Inventor), Heidi Lopez De Diego (Inventor), Rene Holm (Inventor)

Research output: Patent

Abstract

1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

Original languageEnglish
IPCC07D 295/ 096 A I
Patent numberUS2017360777
Country/TerritoryDenmark
Priority date10/08/2017
Priority numberUS201715674043
Publication statusPublished - 21. Dec 2017
Externally publishedYes

Fingerprint

Dive into the research topics of '1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment'. Together they form a unique fingerprint.

Cite this